Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-116
Closed -$36K 80
2025
Q1
$36K Buy
116
+1
+0.9% +$295 0.02% 133
2024
Q4
$29.9K Sell
115
-3
-3% -$890 0.02% 141
2024
Q3
$38K Buy
118
+1
+0.9% +$327 0.03% 127
2024
Q2
$36.6K Hold
117
0.03% 122
2024
Q1
$33.3K Sell
117
-138
-54% -$40.4K 0.02% 129
2023
Q4
$73.4K Buy
255
+137
+116% +$37.3K 0.05% 80
2023
Q3
$31.7K Buy
+118
New +$29.4K 0.03% 103
2022
Q4
Sell
-10
Closed -$2K 162
2022
Q3
$2K Hold
10
0.02% 178
2022
Q2
$2K Hold
10
0.02% 177
2022
Q1
$2K Hold
10
﹤0.01% 151
2021
Q4
$2K Buy
+10
New +$2.11K ﹤0.01% 160

Other funds holding AMGN

FSC Wealth Advisors's AMGN Position: Q2 2025 in Review

FSC Wealth Advisors sold out of Amgen (AMGN) in Q2 2025, closing a stake of 116 shares — an estimated $36K sold.

FSC Wealth Advisors first reported a position in AMGN in Q4 2021 and held it in 11 quarters. The position peaked at $73.4K in Q4 2023. 2,851 funds tracked by Wall St. Rank hold AMGN as of Q2 2025.

  • FSC Wealth Advisors reported no remaining Amgen position as of Q2 2025 after selling out during the quarter.
  • FSC Wealth Advisors sold 116 Amgen shares in Q2 2025, an estimated $36K.
  • FSC Wealth Advisors first reported a position in Amgen in Q4 2021 and held it in 11 quarters.
  • FSC Wealth Advisors's Amgen position peaked at $73.4K in Q4 2023.
  • 2,851 funds tracked by Wall St. Rank held Amgen as of Q2 2025.

Based on FSC Wealth Advisors's 13F filing for Q2 2025, filed 11 Aug 2025.